Actinium Pharmaceuticals (ATNM) Stock Chart & Stock Price History $1.46 -0.06 (-3.95%) As of 03:48 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Actinium Pharmaceuticals Stock Price Performance The Actinium Pharmaceuticals (ATNM) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 15.87%. In the past month, the stock has increased 10.61%, reflecting recent market activity. As of the latest close, Actinium Pharmaceuticals traded at $1.52 with a market cap of $47.42 million and volume of 191,828 shares. Five years ago, the stock traded at a split-adjusted price of $0.18, representing a 711.11% increase over that period. At the time, it had a market cap of $29.86 million and a volume of 4.31 million shares. Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.35%1 Month Performance+10.61%3 Month Performance+26.96%Year-To-Date Performance+15.87%5 Year Performance+711.11% ATNM Stock Chart for Wednesday, May, 14, 2025 ATNM Chart by TradingView Actinium Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2025$1.55$1.52-1.94%$1.57$1.45191,828 shs$47.42 million05/12/2025$1.48$1.55+4.73%$1.59$1.47222,662 shs$48.35 million05/09/2025$1.43$1.48+3.50%$1.53$1.41160,476 shs$46.17 million05/08/2025$1.40$1.43+2.14%$1.49$1.35148,902 shs$44.61 million05/07/2025$1.38$1.40+1.45%$1.42$1.36179,252 shs$43.67 million05/06/2025$1.50$1.38-8.00%$1.51$1.38315,601 shs$43.05 million05/05/2025$1.55$1.50-3.23%$1.62$1.47247,133 shs$46.79 million05/02/2025$1.49$1.55+4.03%$1.64$1.54376,183 shs$48.35 million05/01/2025$1.52$1.49-1.97%$1.54$1.43317,965 shs$46.48 million04/30/2025$1.43$1.52+6.29%$1.52$1.35517,309 shs$47.42 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/29/2025$1.30$1.43+10.00%$1.57$1.30810,625 shs$44.61 million04/28/2025$1.31$1.30-0.76%$1.43$1.25552,393 shs$40.56 million04/25/2025$1.27$1.31+3.15%$1.36$1.21321,407 shs$40.87 million04/24/2025$1.30$1.27-2.31%$1.40$1.26339,430 shs$39.62 million04/23/2025$1.38$1.30-5.80%$1.45$1.27320,486 shs$40.56 million04/22/2025$1.20$1.38+15.00%$1.39$1.23578,411 shs$43.05 million04/21/2025$1.21$1.20-0.83%$1.21$1.17259,502 shs$37.44 million04/18/2025$1.21$1.21$1.24$1.17323,422 shs$37.75 million04/17/2025$1.25$1.21-3.20%$1.24$1.17323,422 shs$37.75 million04/16/2025$1.26$1.25-0.79%$1.26$1.19188,035 shs$39.00 million04/15/2025$1.32$1.26-4.55%$1.34$1.18393,609 shs$39.31 million04/14/2025$1.30$1.32+1.54%$1.34$1.24357,781 shs$41.18 million Related Companies Eledon Pharmaceuticals Stock Price Chart Inventiva Stock Price Chart Phathom Pharmaceuticals Stock Price Chart Inhibrx Stock Price Chart Cardiff Oncology Stock Price Chart biote Stock Price Chart INmune Bio Stock Price Chart Larimar Therapeutics Stock Price Chart AC Immune Stock Price Chart DiaMedica Therapeutics Stock Price Chart Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ATNM) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored“America is running out of power” - The Washington PostAccording to The Washington Post, AI is causing America to “run out of power”... It’s true — utility compan...True Market Insiders | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | SponsoredBITCOIN Liquidity pools are the backbone of crypto—and right now, they’re exploding with activity. By providing liqui...Awesomely, LLC | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
